Have a personal or library account? Click to login
The altered circadian pattern of basal insulin requirements – an early marker of autoimmune polyendocrine syndromes in type 1 diabetes mellitus Cover

The altered circadian pattern of basal insulin requirements – an early marker of autoimmune polyendocrine syndromes in type 1 diabetes mellitus

Open Access
|May 2020

References

  1. Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes 13, 1–5, 2012.10.1111/j.1399-5448.2011.00777.x21545675
  2. Cartwright A, Wallymahmed M, Macfarlane IA, Wallymahmed A, Williams G, Gill GV. The outcome of brittle type 1 diabetes-a 20 year study. QJM 104, 575–579, 2011.10.1093/qjmed/hcr01021285231
  3. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 45, 937–948, 2002.10.1007/s00125-002-0822-912136392
  4. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28, 1245–1249, 2005.10.2337/diacare.28.5.124515855602
  5. Eisenbarth GS, Wilson PW, Ward F, Buckley C, Lebovita H. The polyglandular failure syndrome: disease inheritance, HLA type, and immune function. Ann Intern Med 91, 528–533, 1979.10.7326/0003-4819-91-4-528314765
  6. Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med 25, 501–504, 2008.10.1111/j.1464-5491.2008.02413.x18387080
  7. IDF: IDF Diabetes Atlas. Eighth edition, 2017. Retrieved from http://www.diabetesatlas.org
  8. Krieger DT, Allen W, Rizzo F, Krieger HP. Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32, 266–284, 1971.10.1210/jcem-32-2-2664321505
  9. Laimer M, Melmer A, Mader JK, Schutz-Fuhrmann I, Engels HR, Gotz G, Pfeifer M, Hermann JM, Stettler C, Holl RW. Variability of basal rate profiles in insulin pump therapy and association with complications in type 1 diabetes mellitus. PLoS One 11, e0150604, 2016.10.1371/journal.pone.0150604477750326938444
  10. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C, Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329, 977–986, 1993.10.1056/NEJM1993093032914018366922
  11. Nathan DM. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37, 9–16, 2014.10.2337/dc13-2112386799924356592
  12. Neufeld M, Blizzard R. Polyglandular autoimmune diseases. In A. Pinchera, D. Doniach, G. Fenzi, L. Baschieri (Eds.), Symposium on Autoimmune Aspects of Endocrine Disorders, pp. 357–365, New York, Academic Press, 1980.
  13. Robles DT, Fain PR, Gottlieb PA, Eisenbarth GS. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 31, 353–368, vi–vii, 2002.10.1016/S0889-8529(01)00015-9
  14. Russell W, Harrison RF, Smith N, Darzy K, Shalet S, Weetman AP, Ross RJ. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J Clin Endocrinol Metab 93, 2300–2306, 2008.10.1210/jc.2007-2674
  15. Samaan NA. Hypoglycemia secondary to endocrine deficiencies. Endocrinol Metab Clin North Am 18, 145–154, 1989.10.1016/S0889-8529(18)30393-1
  16. Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabetes Res Clin Pract 69, 14–21, 2005.10.1016/j.diabres.2004.11.00515955383
  17. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, 1384–1395, 2013.10.2337/dc12-2480363186723589542
  18. Shah JH, Motto GS, Papagiannes E, Williams GA. Insulin metabolism in hypothyroidism. Diabetes 24, 922–925, 1975.10.2337/diabetes.24.10.922
  19. Skordis N, Maclaren N. Chapter 15: Immunogenetics of autoimmune polyglandular syndromes. In N. Farid (Ed.), Immunogenetics of endocrine disorders, pp. 373–399, New York, Alan R. Liss, Inc., 1988.
  20. Sperling M, Yau M. Autoimmune Polyglandular Syndromes. In K. R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J. M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J. E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D. L. Trence, A. Vinik, & D. P. Wilson (Eds.), Endotext. South Dartmouth (MA): MDText.com, Inc., 2000.
DOI: https://doi.org/10.2478/enr-2020-0015 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 126 - 132
Published on: May 8, 2020
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Maria Pallayova, Dagmar Breznoscakova, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.